Amgen (AMGN) Stock Pops After Morgan Stanley Upgrade to Overweight
Tweet Send to a Friend
Morgan Stanley analyst Matthew Harrison upgraded shares of Amgen (NASDAQ: AMGN) to Overweight with a price target of $279 per ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
